Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6315)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Zhu DY, Guo QS, Li YL, Cui B, Guo J, Liu JX, Li P. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i48/18306.htm |
| Number | Citing Articles |
| 1 |
Tony Navas, Robert J. Kinders, Scott M. Lawrence, Katherine V. Ferry-Galow, Suzanne Borgel, Melinda G. Hollingshead, Apurva K. Srivastava, Sergio Y. Alcoser, Hala R. Makhlouf, Rodrigo Chuaqui, Deborah F. Wilsker, Mariam M. Konaté, Sarah B. Miller, Andrea Regier Voth, Li Chen, Tomas Vilimas, Jyothi Subramanian, Lawrence Rubinstein, Shivaani Kummar, Alice P. Chen, Donald P. Bottaro, James H. Doroshow, Ralph E. Parchment. Clinical Evolution of Epithelial–Mesenchymal Transition in Human Carcinomas. Cancer Research 2020; 80(2): 304 doi: 10.1158/0008-5472.CAN-18-3539
|
| 2 |
Jihyun Park, Sun Young Kim, Ha-Jung Kim, Kyoung-Mee Kim, Eun Young Choi, Myung-Soo Kang. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth. Oncotarget 2016; 7(19): 28670 doi: 10.18632/oncotarget.8764
|
| 3 |
Akira Ooki, Kensei Yamaguchi. The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration. Gastric Cancer 2021; 24(6): 1169 doi: 10.1007/s10120-021-01235-z
|
| 4 |
Dai Shimizu, Mitsuro Kanda, Haruyoshi Tanaka, Daisuke Kobayashi, Chie Tanaka, Masamichi Hayashi, Naoki Iwata, Yukiko Niwa, Hideki Takami, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Michitaka Fujiwara, Yasuhiro Kodera. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer. Scientific Reports 2017; 7(1) doi: 10.1038/srep42089
|
| 5 |
Jinglin Zhang, Patrick M. K. Tang, Yuhang Zhou, Alfred S. L. Cheng, Jun Yu, Wei Kang, Ka Fai To. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis. Cells 2019; 8(6): 637 doi: 10.3390/cells8060637
|
| 6 |
Victoria da Silva-Diz, Pilar Simón-Extremera, Adrià Bernat-Peguera, Jana de Sostoa, Maria Urpí, Rosa M. Penín, Diana Pérez Sidelnikova, Oriol Bermejo, Joan Maria Viñals, Annie Rodolosse, Eva González-Suárez, Antonio Gómez Moruno, Miguel Ángel Pujana, Manel Esteller, Alberto Villanueva, Francesc Viñals, Purificación Muñoz. Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression. Cancer Research 2016; 76(5): 1245 doi: 10.1158/0008-5472.CAN-15-1631
|
| 7 |
QIONG FAN, MEI-TING QIU, ZHU ZHU, JIN-HUA ZHOU, LIMO CHEN, YE ZHOU, WEI GU, LI-HUA WANG, ZHU-NAN LI, YING XU, WEI-WEI CHENG, DAN WU, WEI BAO. Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway. Oncology Reports 2015; 34(4): 1787 doi: 10.3892/or.2015.4143
|
| 8 |
Richard J. Epstein, Li Jun Tian, Yan Fei Gu, Chandra Singh. 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9955456
|
| 9 |
Yuki Yajima, Akemi Kosaka, Kei Ishibashi, Shunsuke Yasuda, Hiroki Komatsuda, Toshihiro Nagato, Kensuke Oikawa, Masahiro Kitada, Masanori Takekawa, Takumi Kumai, Kenzo Ohara, Takayuki Ohkuri, Hiroya Kobayashi. A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. Cancer Science 2022; 113(8): 2526 doi: 10.1111/cas.15429
|
| 10 |
F. Norozi, A. Ahmadzadeh, M. Shahjahani, S. Shahrabi, N. Saki. Twist as a new prognostic marker in hematological malignancies. Clinical and Translational Oncology 2016; 18(2): 113 doi: 10.1007/s12094-015-1357-0
|
| 11 |
Hiroki Harada, Kei Hosoda, Hiromitsu Moriya, Hiroaki Mieno, Akira Ema, Marie Washio, Mariko Kikuchi, Yoshimasa Kosaka, Masahiko Watanabe, Keishi Yamashita. Carcinosarcoma of the esophagus: A report of 6 cases associated with zinc finger E‑box‑binding homeobox 1 expression. Oncology Letters 2018; doi: 10.3892/ol.2018.9585
|
| 12 |
Ana Vila, Miguel Abal, Laura Muinelo-Romay, Carlos Rodriguez-Abreu, José Rivas, Rafael López-López, Clotilde Costa, Jung Weon Lee. EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation. PLOS ONE 2016; 11(10): e0163705 doi: 10.1371/journal.pone.0163705
|
| 13 |
Qianjin Li, Lishann Ingram, Sungjin Kim, Zanna Beharry, Jonathan A. Cooper, Houjian Cai. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression. Neoplasia 2018; 20(3): 233 doi: 10.1016/j.neo.2018.01.006
|
| 14 |
Lin Song, Xin Zhou, Hong-Jun Jia, Mei Du, Jin-Ling Zhang, Liang Li. Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice. Asian Pacific Journal of Tropical Medicine 2016; 9(8): 796 doi: 10.1016/j.apjtm.2016.06.004
|
| 15 |
Joon Hyung Jhi, Gwang Ha Kim, Su Jin Park, Dong Uk Kim, Moon Won Lee, Bong Eun Lee, Chae Hwa Kwon, Yoon-Kyoung Cho. Circulating Tumor Cells and TWIST Expression in Patients with Metastatic Gastric Cancer: A Preliminary Study. Journal of Clinical Medicine 2021; 10(19): 4481 doi: 10.3390/jcm10194481
|
| 16 |
Masakazu Yashiro, Tasuku Matsuoka. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer. World Journal of Gastroenterology 2016; 22(8): 2415-2423 doi: 10.3748/wjg.v22.i8.2415
|
| 17 |
Jiao Ma, Jiajia Li, Ying Wang, Weiling Chen, Peiyong Zheng, Yueqiang Chen, Zhenping Sun, Jin Liu, Yin Zhou, Jianyi Wang, Sheng Liu, Xianghui Han. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling. Biomedicine & Pharmacotherapy 2020; 121: 109617 doi: 10.1016/j.biopha.2019.109617
|
| 18 |
Zhenkun Weng, Cheng Xu, Xiu Chen, Qing Yan, Zuqiang Fu, Jian Jiao, Jin Xu, Qian Liu, Dongmei Wang, Jingjia Liang, Wenxiang Li, Aihua Gu. Sp1-activated FGFR2 is involved in early-life exposure to nickel-induced craniosynostosis by regulating the ERK1/2 signaling pathway. Environment International 2024; 184: 108477 doi: 10.1016/j.envint.2024.108477
|
| 19 |
Ming Han, Wanpeng Xu. EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells. Tumor Biology 2017; 39(7): 101042831771840 doi: 10.1177/1010428317718404
|
| 20 |
Tingzeng Wang, Okkyung Rho, Fernando Eguiarte‐Solomon, John DiGiovanni. Twist1 as a target for prevention of cutaneous squamous cell carcinoma. Molecular Carcinogenesis 2023; 62(1): 62 doi: 10.1002/mc.23482
|
| 21 |
Masakazu Yashiro, Kenji Kuroda, Go Masuda, Tomohisa Okuno, Yuichiro Miki, Yurie Yamamoto, Tomohiro Sera, Atsushi Sugimoto, Shuhei Kushiyama, Sadaaki Nishimura, Shingo Togano, Masaichi Ohira. Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84107-x
|
| 22 |
Ke Chen, Ji Xu, Yu-ling Tong, Jia-Fei Yan, Yu Pan, Wei-jia Wang, Li Zheng, Xiao-xiao Zheng, Can Hu, Xiu Hu, Xian Shen, Wei Chen. Rab31 promotes metastasis and cisplatin resistance in stomach adenocarcinoma through Twist1-mediated EMT. Cell Death & Disease 2023; 14(2) doi: 10.1038/s41419-023-05596-4
|